Use of a rotary bioartificial liver in the differentiation of human liver stem cells

Tissue Engineering - Part C: Methods

Volumn 16, Issue 1, 2010, Pages 123-132

  Fonsato, Valentina ^a   Herrera, Maria Beatriz ^a   Buttiglieri, Stefano ^a   Gatti, Stefano ^b   Camussi, Giovanni ^a   Tetta, Ciro ^c  

^a MOLINETTE HOSPITAL   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c FRESENIUS MEDICAL CARE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; BIOACTIVITY; BIOLOGICAL MATERIALS PRESERVATION; CELL CULTURE; LIVER; METABOLISM; PEPTIDES; UREA;

A-DENSITY; BIOARTIFICIAL LIVER; CELL DIFFERENTIATION; CELL-BASED; CYTOCHROME P450; GROWTH FACTOR; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMAN LIVER; MESENCHYMAL STEM CELL; PERFUSION SYSTEM; POLYSULPHONE MEMBRANES; STEM CELL; STEM CELL DIFFERENTIATION;

STEM CELLS;

INDOCYANINE GREEN; PERIODIC ACID; SCATTER FACTOR;

ARTICLE; ARTIFICIAL LIVER; CELL CULTURE; CELL DIFFERENTIATION; CRYOPRESERVATION; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; LIVER; LIVER CELL; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; PATHOLOGY; STEM CELL; TIME; TISSUE ENGINEERING;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CRYOPRESERVATION; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; INDOCYANINE GREEN; LIVER; LIVER, ARTIFICIAL; MESENCHYMAL STEM CELLS; PERIODIC ACID; STEM CELLS; TIME FACTORS; TISSUE ENGINEERING;

EID: 77952410564     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2008.0634     Document Type: Article

References (27)

1. Mangnall, D., Bird, N.C., and Majeed, A.W. The molecular physiology of liver regeneration following partial hepatec-tomy. Liver Int 23, 124, 2003.
2. Reinehr, R., Sommerfeld, A., and Häussinger, D. CD95 li-gand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells. Gastroenterology 134, 1494, 2008.
3. Hogaboam, C.M., Simpson, K.J., Chensue, S.W., Steinhauser, M.L., Lukacs, N.W., Gauldie, J., Strieter, R.M., and Kunkel, S.L. Macrophage inflammatory protein-2 gene therapy attenuates adenovirus-and acetaminophen-mediated hepatic injury. Gene Ther 6, 573, 1999.
4. Ren, X., Carpenter, A., Hogaboam, C., and Colletti, L. Mi-togenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatec-tomy in the mouse. Am J Pathol 163, 563, 2003.
5. Tiberio, G.A., Tiberio, L., Benetti, A., Cervi, E., Montani, N., Dreano, M., Garotta, G., Cerea, K., Steimberg, N., Pandolfo, G., Ferrari-Bravo, A., Mazzoleni, G., Giulini, S.M., and Schiaffonati, L. IL-6 promotes compensatory liver regeneration in cirrhotic rat after partial hepatectomy. Cytokine 42, 372, 2008.
6. Natarajan, A., Wagner, B., and Sibilia, M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA 104, 17081, 2007.
7. Zhang, L., Theise, N., Chua, M., and Reid, L.M. The stem cell niche of human livers: symmetry between development and regeneration. Hepatology 48, 1598, 2008.
8. Herrera, M.B., Bruno, S., Buttiglieri, S., Tetta, C., Gatti, S., Deregibus, M.C., and Camussi, G. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24, 2840, 2006.
9. Kamohara, Y., Rozga, J., and Demetriou, A.A. Artificial liver: review and Cedars-Sinai experience. J Hepatobiliary Pancreat Surg 5, 273, 1998.
10. Gerlach, J.C., Zeilinger, K., and Patzer, I.J.F. Bioartificial liver systems: why, what, whither? Regen Med 3, 575, 2008.
11. McKenzie, T.J., Lillegard, J.B., and Nyberg, S.L. Artificial and bioartificial liver support. Semin Liver Dis 28, 210, 2008.
12. Kobayashi, N., Okitsu, T., and Tanaka, N. Cell choice for bioartificial livers. Keio J Med 52, 151, 2003.
13. Pless, G., and Sauer, I.M. Bioartificial liver: current status. Transplant Proc 37, 3893, 2005.
14. Dixit, V., and Gitnick, G. The bioartificial liver: state-of-the-art. Eur J Surg Suppl 582, 71, 1998.
15. Kaido, T. Randomized controlled trials involving liver failure. Hepatogastroenterology 55, 1089, 2008.
16. Chamberlain, G., Fox, J., Ashton, B., and Middleton, J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features and potential for homing. Stem Cells 25, 2739, 2007.
17. Kosai, K., Matsumoto, K., Funakoshi, H., and Nakamura, T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 30, 151, 1999.
18. Wurm, M., Lubei, V., Caronna, M., Hermann, M., Mar-greiter, R., and Hengester, P. Development of a novel perfused rotary cell culture system. Tissue Eng 13, 2761, 2007.
19. Wolf, C.F., and Munkelt, B.E. Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. Trans Am Soc Artif Intern Organs 21, 16, 1975.
20. Yanagi, K., Ookawa, K., Mizuno, S., and Ohshima, N. Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel. ASAIO Trans 35, 570, 1989.
21. Kobayashi, N., Taguchi, T., Noguchi, H., Okitsu, T., Totsu-gawa, T., Watanabe, T., Matsumura, T., Fujiwara, T., Urata, H., Kishimoto, N., Hayashi, N., Nakaji, S., Murakami, T., and Tanaka, N. Rapidly functional immobilization of immortalized human hepatocytes using cell adhesive GRGDS peptide-carrying cellulose microspheres. Cell Transplant 10, 387, 2001.
22. Hager, J.C., Carman, R., Stoller, R., Panol, G., Leduc, E.H., Thayer, W.R., Porter, L.E., Galletti, P.M., and Calabresi, P. A prototype for a hybrid artificial liver. Trans Am Soc Artif Intern Organs 24, 250, 1978.
23. Gerlach, J.C., Encke, J., Hole, O., Muller, C., Ryan, C.J., and Neuhaus, P. Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation 58, 984, 1994.
24. Flendrig, L.M., Calise, F., Di, F.E., Mancini, A., Ceriello, A., Santaniello, W., Mezza, E., Sicoli, F., Belleza, G., Bracco, A., Cozzolino, S., Scala, D., Mazzone, M., Fattore, M., Gonzales, E., and Chamuleau, R.A. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs 22, 701, 1999.
25. Abrahamse, S.L., van de Kerkhove, M.P., Sosef, M.N., Hartman, R., Chamuleau, R.A., and van Gulik, T.M. Treatment of acute liver failure in pigs reduces hepatocyte function in a bioartificial liver support system. Int J Artif Organs 25, 966, 2002.
26. Sauer, I.M., Zeilinger, K., Obermayer, N., Pless, G., Grun-wald, A., Pascher, A., Mieder, T., Roth, S., Goetz, M., Kar-dassis, D., Mas, A., Neuhaus, P., and Gerlach, J.C. Primary human liver cells as source for modular extracorporeal liver support\a preliminary report. Int J Artif Organs 25, 1001, 2002.
27. Chamuleau, R., Deurholt, T., and Hoekstra, R. Which are the right cells to be used in a bioartificial liver? Metab Brain Dis 20, 327, 2005.